Systems-Based Technologies in Profiling the Stem Cell Molecular Framework for Cardioregenerative Medicine

Saranya P. Wyles, Randolph S. Faustino, Xing Li, Andre Terzic, Timothy J Nelson

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Over the last decade, advancements in stem cell biology have yielded a variety of sources for stem cell-based cardiovascular investigation. Stem cell behavior, whether to maintain its stable state of pluripotency or to prime toward the cardiovascular lineage is governed by a set of coordinated interactions between epigenetic, transcriptional, and translational mechanisms. The science of incorporating genes (genomics), RNA (transcriptomics), proteins (proteomics), and metabolites (metabolomics) data in a specific biological sample is known as systems biology. Integrating systems biology in progression with stem cell biologics can contribute to our knowledge of mechanisms that underlie pluripotency maintenance and guarantee fidelity of cardiac lineage specification. This review provides a brief summarization of OMICS-based strategies including transcriptomics, proteomics, and metabolomics used to understand stem cell fate and to outline molecular processes involved in heart development. Additionally, current efforts in cardioregeneration based on the “one-size-fits-all” principle limit the potential of individualized therapy in regenerative medicine. Here, we summarize recent studies that introduced systems biology into cardiovascular clinical outcomes analysis, allowing for predictive assessment for disease recurrence and patient-specific therapeutic response.

Original languageEnglish (US)
Pages (from-to)501-510
Number of pages10
JournalStem Cell Reviews and Reports
Volume11
Issue number3
DOIs
StatePublished - Jun 4 2015

Fingerprint

Stem Cells
Medicine
Systems Biology
Technology
Metabolomics
Proteomics
Regenerative Medicine
Genomics
Biological Products
Epigenomics
Cell Biology
Maintenance
RNA
Recurrence
Therapeutics
Genes
Proteins

Keywords

  • Cardiac Regeneration
  • OMICS
  • Stem Cells
  • Systems Biology

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology

Cite this

Systems-Based Technologies in Profiling the Stem Cell Molecular Framework for Cardioregenerative Medicine. / Wyles, Saranya P.; Faustino, Randolph S.; Li, Xing; Terzic, Andre; Nelson, Timothy J.

In: Stem Cell Reviews and Reports, Vol. 11, No. 3, 04.06.2015, p. 501-510.

Research output: Contribution to journalArticle

@article{af4b650dceb4463aab1d20a3c50a92c2,
title = "Systems-Based Technologies in Profiling the Stem Cell Molecular Framework for Cardioregenerative Medicine",
abstract = "Over the last decade, advancements in stem cell biology have yielded a variety of sources for stem cell-based cardiovascular investigation. Stem cell behavior, whether to maintain its stable state of pluripotency or to prime toward the cardiovascular lineage is governed by a set of coordinated interactions between epigenetic, transcriptional, and translational mechanisms. The science of incorporating genes (genomics), RNA (transcriptomics), proteins (proteomics), and metabolites (metabolomics) data in a specific biological sample is known as systems biology. Integrating systems biology in progression with stem cell biologics can contribute to our knowledge of mechanisms that underlie pluripotency maintenance and guarantee fidelity of cardiac lineage specification. This review provides a brief summarization of OMICS-based strategies including transcriptomics, proteomics, and metabolomics used to understand stem cell fate and to outline molecular processes involved in heart development. Additionally, current efforts in cardioregeneration based on the “one-size-fits-all” principle limit the potential of individualized therapy in regenerative medicine. Here, we summarize recent studies that introduced systems biology into cardiovascular clinical outcomes analysis, allowing for predictive assessment for disease recurrence and patient-specific therapeutic response.",
keywords = "Cardiac Regeneration, OMICS, Stem Cells, Systems Biology",
author = "Wyles, {Saranya P.} and Faustino, {Randolph S.} and Xing Li and Andre Terzic and Nelson, {Timothy J}",
year = "2015",
month = "6",
day = "4",
doi = "10.1007/s12015-014-9557-5",
language = "English (US)",
volume = "11",
pages = "501--510",
journal = "Stem Cell Reviews and Reports",
issn = "1550-8943",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - Systems-Based Technologies in Profiling the Stem Cell Molecular Framework for Cardioregenerative Medicine

AU - Wyles, Saranya P.

AU - Faustino, Randolph S.

AU - Li, Xing

AU - Terzic, Andre

AU - Nelson, Timothy J

PY - 2015/6/4

Y1 - 2015/6/4

N2 - Over the last decade, advancements in stem cell biology have yielded a variety of sources for stem cell-based cardiovascular investigation. Stem cell behavior, whether to maintain its stable state of pluripotency or to prime toward the cardiovascular lineage is governed by a set of coordinated interactions between epigenetic, transcriptional, and translational mechanisms. The science of incorporating genes (genomics), RNA (transcriptomics), proteins (proteomics), and metabolites (metabolomics) data in a specific biological sample is known as systems biology. Integrating systems biology in progression with stem cell biologics can contribute to our knowledge of mechanisms that underlie pluripotency maintenance and guarantee fidelity of cardiac lineage specification. This review provides a brief summarization of OMICS-based strategies including transcriptomics, proteomics, and metabolomics used to understand stem cell fate and to outline molecular processes involved in heart development. Additionally, current efforts in cardioregeneration based on the “one-size-fits-all” principle limit the potential of individualized therapy in regenerative medicine. Here, we summarize recent studies that introduced systems biology into cardiovascular clinical outcomes analysis, allowing for predictive assessment for disease recurrence and patient-specific therapeutic response.

AB - Over the last decade, advancements in stem cell biology have yielded a variety of sources for stem cell-based cardiovascular investigation. Stem cell behavior, whether to maintain its stable state of pluripotency or to prime toward the cardiovascular lineage is governed by a set of coordinated interactions between epigenetic, transcriptional, and translational mechanisms. The science of incorporating genes (genomics), RNA (transcriptomics), proteins (proteomics), and metabolites (metabolomics) data in a specific biological sample is known as systems biology. Integrating systems biology in progression with stem cell biologics can contribute to our knowledge of mechanisms that underlie pluripotency maintenance and guarantee fidelity of cardiac lineage specification. This review provides a brief summarization of OMICS-based strategies including transcriptomics, proteomics, and metabolomics used to understand stem cell fate and to outline molecular processes involved in heart development. Additionally, current efforts in cardioregeneration based on the “one-size-fits-all” principle limit the potential of individualized therapy in regenerative medicine. Here, we summarize recent studies that introduced systems biology into cardiovascular clinical outcomes analysis, allowing for predictive assessment for disease recurrence and patient-specific therapeutic response.

KW - Cardiac Regeneration

KW - OMICS

KW - Stem Cells

KW - Systems Biology

UR - http://www.scopus.com/inward/record.url?scp=84930614073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930614073&partnerID=8YFLogxK

U2 - 10.1007/s12015-014-9557-5

DO - 10.1007/s12015-014-9557-5

M3 - Article

VL - 11

SP - 501

EP - 510

JO - Stem Cell Reviews and Reports

JF - Stem Cell Reviews and Reports

SN - 1550-8943

IS - 3

ER -